ROSENBERG MORRIS 4
4 · SEATTLE GENETICS INC /WA · Filed Apr 24, 2012
Insider Transaction Report
Form 4
ROSENBERG MORRIS
EVP, Development
Transactions
- Exercise/Conversion
Common Stock
2012-04-20$5.63/sh+38,281$215,522→ 55,924 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-04-20−38,281→ 0 totalExercise: $5.63Exp: 2016-01-31→ Common Stock (38,281 underlying) - Sale
Common Stock
2012-04-20$19.51/sh−38,281$746,862→ 17,643 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Rosenberg on March 15, 2012.
- [F2]Amount of securities beneficially owned following reported transactions includes 17,643 Restricted Stock Units subject to vesting.
- [F3]Shares shall vest at a rate of 25% on 1/31/07 and monthly thereafter until all the shares are fully vested on 1/31/10.